BioCentury | May 18, 2018
Clinical News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...BioCentury, March 30) . US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | May 16, 2018
Company News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...which had Priority Review. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Mar 30, 2018
Clinical News

FDA panel backs US WorldMeds' opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Mar 9, 2018
Clinical News

FDA panel to review US WorldMeds' opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Dec 1, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Nov 21, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Jul 28, 2014
Clinical News

APL-130277: Phase II started

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Jun 2, 2014
Clinical News

Cynapsus preclinical data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Apr 21, 2014
Clinical News

APL-130277: Interim pilot trial data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Jan 20, 2014
Clinical News

APL-130277: Pilot trial data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
Items per page:
1 - 10 of 34
BioCentury | May 18, 2018
Clinical News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...BioCentury, March 30) . US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | May 16, 2018
Company News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...which had Priority Review. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Mar 30, 2018
Clinical News

FDA panel backs US WorldMeds' opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Mar 9, 2018
Clinical News

FDA panel to review US WorldMeds' opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Dec 1, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Nov 21, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...to manage opioid withdrawal. US WorldMeds obtained U.S. rights to lofexidine from Britannia Pharmaceuticals Ltd. in 2003. Britannia...
BioCentury | Jul 28, 2014
Clinical News

APL-130277: Phase II started

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Jun 2, 2014
Clinical News

Cynapsus preclinical data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Apr 21, 2014
Clinical News

APL-130277: Interim pilot trial data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
BioCentury | Jan 20, 2014
Clinical News

APL-130277: Pilot trial data

...data on safety and efficacy from the scientific literature or from previously approved products. The Britannia...
Items per page:
1 - 10 of 34